Maximilian Fleischmann

1PUBLICATIONS
1CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jan 29, 2026
Targeting MCL-1 and MAPK overcomes venetoclax resistance in FLT3-ITD-positive AML cells harbouring activating PTPN11 (SHP-2) mutations.

Maximilian Fleischmann, Ole Hansen, Diana Voigtländer

Pageof 1

Frequent Collaborators

1 joint publications

Ulf Schnetzke